SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending amid reports of potential partnerships and investments from industry giants like Apple and TSMC, fueling speculation about its comeback in the semiconductor market. The community is buzzing with excitement, viewing these developments as a significant catalyst for growth and a validation of Intel's strategic pivot. Many anticipate further gains, driven by a combination of government support and renewed confidence in Intel's ability to compete in the AI and foundry space.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as a 'free and fair' meme coin on the Bitcoin blockchain, with the community emphasizing its decentralized nature and organic growth. Discussions revolve around accumulating during dips and the potential for 'DOG-TOBER', while some debate its relationship with $CBLO. The community continues to highlight its strong fundamentals and unique position within the meme coin landscape.

Pupu is a community-driven meme project centered around the character “Pupu the Frog,” who represents lighthearted fun and adventure within the crypto space. The project aims to build a digital ecosystem where holders can engage with the narrative of Pupu through memes, social interactions, and community activities. At its core, the project highlights creativity, entertainment, and community participation as primary utilities, while maintaining a transparent and decentralized structure that evolves through user engagement.

Pupu

$PUPU.X is trending as the community discusses its potential, drawing comparisons to previous meme coin success stories like $PEPE. Many users are highlighting its accessibility and ease of purchase through the Phantom Wallet on the Solana network.

BTQ Technologies Corp. engages in the business of post-quantum encryption. It focuses on applications to the blockchain industry. Its products include PQScale, Keelug, Kenting, Preon, QPoW, and QByte. The company was founded by Nicolas Roussy Newton on March 26, 2021 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQQF is trending as investors discuss its upcoming Nasdaq listing and potential impact on institutional investment. Community members are weighing the potential for share dilution following the uplisting, drawing parallels to a similar situation with DEFT. Optimistic investors believe the listing and government quantum requirements could drive significant growth, while others express concern over potential short-term volatility.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is trending due to a recently announced $1.1B convertible notes offering and a $3B AI hosting agreement with Fluidstack, backed by Google. While the offering initially sparked concerns about dilution, the community is weighing this against the potential for growth and expansion into HPC, with some seeing it as a strategic move. Bullish sentiment highlights Google's involvement and long-term prospects in the AI data center space.

Aventus Network

Aventus Network ($AVT.X) is trending as traders discuss its potential for a breakout, citing bullish chart setups and a low market cap. Community members are highlighting real-world partnerships and the possibility of Polkadot integration acting as a catalyst. Some users are pointing to its limited supply and Coinbase listing as factors that could drive significant price movement.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave ($CRWV) is trending amid discussions around its relationship with OpenAI and the broader AI infrastructure landscape, with community members debating the sustainability of its growth and comparing its valuation to peers. Some are pointing to insider selling and technical chart patterns, while others remain bullish, citing strong partnerships and potential for future growth in the AI sector. The stock's volatility and potential for both gains and losses are also being actively discussed.

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals is trending due to FDA approval for Palsonify, their oral acromegaly drug, sparking excitement among retail traders. The community is focused on the drug's potential impact and pricing, while anticipating a significant price movement. High institutional ownership and short interest are also fueling discussions about a potential short squeeze.

Diginex Ltd. (Hong Kong) is a blockchain financial services and technology company. Its products include diginexESG, diginexLUMEN, diginexAPPRISE, diginexLUMEN Pro, and CSRD framework. The company was founded by Miles Christian Pelham on May 15, 2020 and is headquartered in London, the United Kingdom.

Diginex Ltd.

Diginex ($DGNX) is trending as traders discuss its recent volatility and potential acquisitions, including Resulticks and Findings, which could transform it into a broad technology platform. Community members are also highlighting existing partnerships with major companies and significant investments from Abu Dhabi, suggesting long-term growth potential. Some are comparing $DGNX to other stocks with similar patterns, referencing possible high reward but high risk.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

Aquestive Therapeutics ($AQST) is trending following CEO Barber's appearance on Mad Money, where he highlighted the blockbuster potential of their oral allergy film, Anaphylm. The community is buzzing about the positive interview and the future prospects of the company, with some speculating a buyout. Some are also discussing the competitive landscape, particularly in relation to $SPRY.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tempus AI Enhances Cancer Research Tools With FDA-Cleared xR IVD

TEM secures FDA clearance for its xR IVD device, advancing RNA-based cancer research and precision medicine tools.

Hims & Hers Expands Care Ecosystem via Global and Digital Innovation

HIMS is scaling globally with AI-powered care, new treatments and an $870 million boost to expand its digital ecosystem.

TEM Strengthens Radiology Portfolio With Pixel's FDA Clearance

Tempus AI secures FDA clearance for its updated Pixel cardiac imaging platform, boosting radiology precision and efficiency.

Tempus (TEM) Stock Jumps 13.6%: Will It Continue to Soar?

Tempus (TEM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

TEM Gains Validation for PurIST Amid Evolving Cancer Care Landscape

Tempus AI's PurIST test secures clinical validation, helping personalize treatment choices for advanced pancreatic cancer patients.

TEM Q2 Revenues Soar Amid Coverage Issues: Time to Buy, Hold or Sell?

Tempus AI posts 89.6% Q2 revenue growth, raises 2025 sales outlook again, and sees positive adjusted EBITDA ahead. What is the investment outlook?

What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum?

TEM's Q2 net loss narrows sharply, driven by surging genomics revenues, higher gross profits and tighter cost controls.

Hims & Hers Scales Growth Through Subscriptions and Care Expansion

HIMS fuels growth through subscriptions, expanding care offerings and building proprietary health infrastructure at scale.

Tempus' Key Acquisitions Strengthen Its AI Healthcare Leadership

TEM accelerates its healthcare edge with Paige, Deep 6 AI, and Ambry Genetics acquisitions, expanding data, tech and clinical reach.

Tempus AI or Butterfly: Which AI Health Tech Stock is a Buy Now?

BFLY trades at distressed levels with analyst targets signaling sharp upside, while TEM's premium valuation tempers its appeal.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

$5,000

$6,000

$7,000

$8,000

What price will Ethereum hit in 2025? 
 
*Powered by Polymarket

TEM
Tempus AI Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TEM News

TEM Tempus AI Inc